Ovarian response is associated with anogenital distance in patients undergoing controlled ovarian stimulation for IVF

被引:23
|
作者
Fabregues, F. [1 ]
Gonzalez-Foruria, I. [1 ]
Penarrubia, J. [1 ]
Carmona, F. [1 ]
机构
[1] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Inst Clin Gynecol Obstet & Neonatol, Hosp Clin,Fac Med, Barcelona, Spain
关键词
anogenital distance; ovarian reserve; ovarian response; prenatal exposures; endocrine disruptors; anti-Mullerian hormone; antral follicle count; REPRODUCTIVE DEVELOPMENT; PHTHALATE EXPOSURE; ANDROGEN EXPOSURE; FOLLICLE FORMATION; IN-UTERO; RESERVE; WOMEN; AGE; INDIVIDUALIZATION; TESTOSTERONE;
D O I
10.1093/humrep/dey244
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
STUDY QUESTION: Is the length of the anogenital distance (AGD) a biomarker of ovarian reserve and response to controlled ovarian stimulation (COS)? SUMMARY ANSWER: Shorter AGD is associated with presence of poor ovarian response. WHAT IS KNOWN ALREADY: Organ development during prenatal life is influenced by the prevailing intrauterine environment, and it has been suggested that nutritional, environmental and toxic factors could affect ovarian reserve set prenatally. AGD is a biomarker of prenatal-hormonal environment and observational studies have shown an association between its length and reproductive parameters in both sexes. STUDY DESIGN, SIZE, DURATION: This was a prospective cohort study of 437 women treated with IVF/ICSI conducted in a tertiary-care university hospital between January and December 2016. PARTICIPANTS/MATERIALS, SETTING, METHODS: All women underwent their first COS for IVF/ICSI and reached criteria for oocyte retrieval. Based on the number of oocytes obtained, patients were divided into three groups: poor responders (<= 3 oocytes) (n=50), normoresponders (4-15 oocytes) (n=332) and high responders (> 15 oocytes) (n=55). Before retrieval, the following patient data were recorded: age, body mass index (BMI), ovarian reserve markers (anti-Mullerian hormone [AMH], antral follicle count [AFC] and follicular stimulation hormone [FSH]), cause of infertility, total doses of gonadotropins used and ovarian sensitivity index (OSI). Patients with previous pregnancies, polycystic ovary syndrome (PCOS), endometriosis and previous ovarian or genital surgery were excluded. Anthropometric biomarkers of AGD(AC) (anus-clitoris) and AGD(AF) (anus-fourchette) were measured in all patients under sedation on the day of retrieval and before proceeding to oocyte pick-up. Multiple linear regression analyses were used to examine the association between both AGD and ovarian reserve markers, the total units of gonadotropins used, the number of oocytes obtained and the OSI. Logistic regression was used to predict poor response in COS for IVF/ICSI, while accounting for confounders such as age and BMI. MAIN RESULTS AND THE ROLE OF CHANCE: Baseline FSH, AMH, AFC and age were significantly different among the three groups of ovarian response, as were the units of gonadotropin used, and the ovarian sensitivity index (OSI) (P<0.001). Both AGD(AC) and AGD(AF) measurements were positively correlated with AMH levels (r=0.38 and r=0.21; P<0.05), AFC (r=0.41 and r=0.20; P<0.05), the OSI (r=0.24 and r=0.19; P<0.05) and the number of oocytes retrieved (r=0.29 and r=0.28, respectively; P<0.05). Conversely, there was a negative correlation between both AGD measurements and the doses of gonadotropins used (r=-0.19 and r=-0.15; P<0.05). The area under the curve (AUC) for prediction of poor response of AGD(AC) was 0.70 (95% CI 0.66, 0.75), which was comparable to the classic ovarian reserve markers, such as AFC and AMH. AGD(AF) showed a significantly worse predictive capacity for poor ovarian response (AUC 0.60 [95% CI 0.55, 0.60]) than AMH and AFC. LIMITATIONS, REASONS FOR CAUTION: The population used for the study was a highly selected group of infertile women who underwent COS for IVF, so the findings of this research may not be applicable for general population. Besides, measurement or selection biases might have been possible and must be considered. WIDER IMPLICATIONS OF THE FINDINGS: The findings of this study suggest that in utero exposure to certain hormonal environments could affect the ovarian reserve set prenatally. STUDY FUNDING/COMPETING INTEREST(S): None. The authors have no competing interests to declare.
引用
收藏
页码:1696 / 1704
页数:9
相关论文
共 50 条
  • [21] "anti-mullerian hormone: Marker for ovarian response in controlled ovarian stimulation for IVF patients": A first pilot study in the Indian population
    Singh N.
    Malik E.
    Banerjee A.
    Chosdol K.
    Sreenivas V.
    Mittal S.
    The Journal of Obstetrics and Gynecology of India, 2013, 63 (4) : 268 - 272
  • [22] Ovarian response to stimulation of HIV-positive patients during IVF treatment: a matched, controlled study
    Martinet, V
    Manigart, Y
    Rozenberg, S
    Becker, B
    Gerard, M
    Delvigne, A
    HUMAN REPRODUCTION, 2006, 21 (05) : 1212 - 1217
  • [23] Ovarian stimulation and oocyte dysmorphismms in IVF patients
    Cobo, A.
    HUMAN REPRODUCTION, 2003, 18 : 107 - 108
  • [24] Ovarian stimulation outcome in infertile women with endometriosis undergoing IVF
    Luca, Alexandru
    Nemescu, Dragos
    Butnaru, Maria
    Butnariu, Andreea
    Onofriescu, Mircea
    GINEKOLOGIA POLSKA, 2016, 87 (01) : 37 - 41
  • [25] Performance of prognostic modelling of high and low ovarian response to ovarian stimulation for IVF
    Scheinhardt, Markus O.
    Lerman, Tamara
    Koenig, Inke R.
    Griesinger, Georg
    HUMAN REPRODUCTION, 2018, 33 (08) : 1499 - 1505
  • [26] The dydrogesterone and FSH protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation in IVF/ICSI cycle
    Gurbuz, A. S.
    Gode, F.
    HUMAN REPRODUCTION, 2019, 34 : 107 - 107
  • [27] Impact of controlled Ovarian Stimulation on the Endothelial cell activation in IVF/ICSI patients
    Toth, B.
    Eichinger, L.
    Geller, A.
    Jesclike, U.
    Friese, K.
    Thaler, C.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 : S15 - S15
  • [28] AFC vs. AMH: prediction of ovarian response in women with endometrioma undergoing controlled ovarian stimulation
    Ersahin, A. A.
    Arpaci, H.
    Ersahin, S. S.
    Celik, N.
    Acet, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (10) : 2499 - 2503
  • [29] The BISTIM study: a randomized controlled trial comparing dual ovarian stimulation (duostim) with two conventional ovarian stimulations in poor ovarian responders undergoing IVF
    Massin, N.
    Abdennebi, I
    Porcu-Buisson, G.
    Chevalier, N.
    Descat, E.
    Pietin-Vialle, C.
    Goro, S.
    Brussieux, M.
    Pinto, M.
    Pasquier, M.
    Bry-Gauillard, H.
    HUMAN REPRODUCTION, 2023, 38 (05) : 927 - 937
  • [30] Improved pregnancy rates with luteinizing hormone supplementation in patients undergoing ovarian stimulation for IVF
    Paterson, Nicole D.
    Foong, Shu C.
    Greene, Calvin A.
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2012, 29 (07) : 579 - 583